Management of comorbid bipolar disorder and substance abuse

Research output: Contribution to journalArticle

4 Scopus citations

Abstract

Rates of alcohol and other substance abuse or dependence disorders are substantially higher in persons with bipolar disorders than in the general population, reaching approximately 61% in patients with bipolar I disorder. As a result, clinicians must be prepared to treat substance use disorders and bipolar disorder simultaneously. This presentation reviews data from the 4 published randomized, controlled trials of pharmacotherapy (lithium, carbamazepine, valproate, and quetiapine) in this population. Also reviewed are data from promising open-label, uncontrolled trials. While the results of published research have been generally positive and support the efficacy and tolerability of several agents from different classes in patients with a dual diagnosis of bipolar disorder and substance abuse or dependence, more randomized, controlled research is needed.

Original languageEnglish (US)
Pages (from-to)e05
JournalJournal of Clinical Psychiatry
Volume67
Issue number8
DOIs
StatePublished - Aug 2006

ASJC Scopus subject areas

  • Psychiatry and Mental health

Fingerprint Dive into the research topics of 'Management of comorbid bipolar disorder and substance abuse'. Together they form a unique fingerprint.

  • Cite this